Article Details

Inmagene Receives FDA's IND Clearance for OX40 Antagonist - PR Newswire

Retrieved on: 2022-05-01 01:35:33

Tags for this article:

Click the tags to see associated articles and topics

Inmagene Receives FDA's IND Clearance for OX40 Antagonist - PR Newswire. View article details on hiswai:

Excerpt

Inmagene is a global clinical-stage biotechnology company focused on developing novel therapeutics for immunology-related diseases.

Article found on: www.prnewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up